Translating Research Into Practice
Molecular Profiling in Resectable Colorectal Liver Metastases: The Role of KRAS Mutation Status in Assessing Prognosis in the Preoperative Setting
Ryanne Coulson, PA-C, MPAS
MD Anderson Cancer Center, Houston, Texas
Author’s disclosures of potential conflicts of interest are found at the end of this article.
Ryanne Coulson, PA-C, MPAS, MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030.
E-mail: rlcoulso@mdanderson.org
J Adv Pract Oncol 2014;6:470–474 |
doi: 10.6004/jadpro.2015.6.5.7 |
© 2015 Harborside Press®
For access to the full length article, please
sign in.
